INTRODUCTION
We have previously reported excess total pediatric mortality (fetal+neonatal+postneonatal) occurring in the Magnesium and Neurologic Endpoints Trial (MagNET). 1 One of the acute deaths in that study occurred in a 26-week-1-day gestation weighing 885 g in whom the electronic fetal heart rate monitoring was reassuring and the umbilical blood gases at delivery were normal, but in whom the Apgar scores were unexpectedly low. Despite sufficient resuscitation, the baby died at 20 minutes of age. The autopsy was essentially normal. Our purpose here is to share with colleagues a recent, similar occurrence following maternal magnesium toxicity, but an occurrence in which we have more supporting data available to us than previously because a twin sibling survived.
CASE REPORT
A 31-year-old primigravida with diamnionic±dichorionic twins was admitted for spontaneous rupture of membranes at 32 weeks, 4 days' gestation. The cervix was found to be 1 cm dilated. Twin A was cephalic and twin B was breech. Electronic fetal monitoring was reassuring. Per hospital protocol for preterm premature rupture of the membranes, the mother was started on prophylactic ampicillin and erythromycin, along with betamethasone. Because she was having some uterine contractions, the mother was given a 4-g bolus of magnesium sulfate (MgSO 4 ) for tocolysis followed by a MgSO 4 infusion of mostly 2.5 g/hr. After nearly a day of tocolysis, a routine maternal serum total magnesium level was found to be 9.0 mg/dl (usual upper limit for therapy is 7.0 mg/dl). On physical examination, the mother was arousable and oriented, although she complained of sleepiness. Deep tendon reflexes were depressed, but still present. In both twins, external fetal monitoring done at this time showed decreased beat-to-beat variability, normal heart rates, and no periodic decelerations. Despite the presence of toxic levels of magnesium, uterine contractions continued to occur (see Figure 1 ). The MgSO 4 infusion was immediately discontinued (total received dose, 51.4 g). During the remainder of the day, the mother continued to labor, progressing to a cervical dilatation of 3 cm. About 42 hours following admission, a decision was made to deliver both fetuses by cesarean section. External fetal monitoring prior to surgery was reassuring.
Unexpectedly, the Apgar scores for twin A were 1/1/0. The neonatal heart rate, which initially had been about 80 beats/min, fell even lower. Despite a vigorous resuscitation, which included the several-time use of intratracheal epinephrine, the baby's myocardium never responded. After 30 minutes, she remained asystolic and was pronounced dead. The umbilical blood gases were reported as having been normal (arterial: pO 2 17 mm Hg, pCO 2 62, pH 7.24, HCO 3 26 mM/l, base excess À4 mM/l; venous: pO 2 26 mm Hg, pCO 2 49, pH 7.29, HCO 3 23 mM/l, base excess À4 mM/l). Of interest, twin B, who had Apgar scores of 4/6/8, was also intubated A 31 -year -old primigravida with twins had spontaneous rupture of the membranes at 32 weeks' gestation. On admission, because of contractions, the mother was started on tocolytic magnesium sulfate ( MgSO 4 ) along with betamethasone and prophylactic antibiotics. About a day later, she was found to have magnesium toxicity. Her serum total magnesium level was 9.0 mg / dl. Tocolysis was immediately discontinued. At cesarean delivery the following day, twin A, a female, died at 30 minutes of age despite a vigorous resuscitation. Although the preceding fetal heart rate patterns had been reassuring and the umbilical blood gases were normal, quite unexpectedly, the Apgar scores were 1 / 1 / 0. An autopsy revealed no anatomic abnormalities. Twin B, a female who survived, was also intubated at delivery. During her stay in the Neonatal Intensive Care Unit, she was found to have modestly elevated levels of serum cardiotroponin T. In our opinion, it is probable that the death of twin A can be directly attributed to magnesium sulfate toxicity. Neonatologists who attend deliveries should be aware that unexpected death may occur in babies who were exposed to high doses of tocolytic MgSO 4 . Journal of Perinatology 2001; 21:261 ± 262.
following delivery, despite normal umbilical blood gases. Twin A weighed 1770 g; twin B weighed 1635 g. At autopsy, the organs of twin A were found to be grossly normal, as was the histopathology. More specifically, the anatomy of the trachea and pharynx was unremarkable, and there was no evidence of pulmonary hypoplasia or pneumonia. Examination of the placenta showed no evidence for chorioamnionitis, funisitis, or abruption. Because twin B survived, additional laboratory studies are available for review. Her serum total magnesium level on the day of delivery (day 0) was 3.9 mg/dl (upper limit of normal 2.5 mg/dl). Neonatal cardiac troponin T levels were: day 2, 0.12; day 6, 0.18; and day 10, 0.09. An electrocardiogram on day 6 showed non-specific ST±T wave abnormalities. On day 13, the follow-up electrocardiogram was normal.
DISCUSSION
In addition to the total pediatric mortality we reported in the Magnesium and Neurologic Endpoints Trial, we have recently reported an association between increased perinatal mortality and exposure to more than 48 g of tocolytic magnesium sulfate. 2 However, prior to now, information concerning the relationship between exposure to the drug and cases of acute death has been less comprehensive than that available to us in this instance. The reasons for such a view are the following: (1) the mother had documented magnesium toxicity and, according to our previous research, when the maternal serum level of magnesium was found to be 9.0 mg/dl, the magnesium level in the fetuses would be even higher at about 10.5 mg/dl; 6 (2) on the day of delivery, the total magnesium level in twin B, a surrogate for twin A, was still 56% (3.9/2.5=1.56) above the upper limit of normal, despite the discontinuation of tocolytic MgSO 4 in the mother more than 21 hours beforehand; (3) both twins had normal umbilical blood gases at delivery, but required resuscitation unexpectedly; (4) the myocardium of twin A, the child who died, did not respond to the administration of cardioactive drugs; (5) surviving twin B was found to have modest elevations in cardiac troponin T, a protein used to monitor myocardial damage in adults with acute infarction; 3 and (6) absence of other plausible mechanisms to explain a sudden and unexpected death in a neonate of more than sufficient birth weight and gestational age to survive.
Although levels of cardiac troponin T may often be higher in newborns than in healthy adults, 4 Shelton et al. 5 recently showed that neonates whose mothers received a median total dose of magnesium sulfate of 51.5 g were statistically significantly more likely to have elevated levels of cardiac troponin T (defined as >0.10 ng/ml) at delivery than were a group in which the median total dose of magnesium sulfate was 28.0 g. Thus, it is conceivable that the mechanism of death in this instance may be directly related to the toxic effects of magnesium on the myocardium of twin A, whereas the myocardium of twin B, although compromised, was sufficiently functional to maintain life. Figure 1 . Representative electronic monitor tracing at the time of maternal magnesium toxicity. Upper heart rate tracing, twin A. Middle heart rate tracing, twin B. Lower heart rate tracing (faint ) , mother. Despite magnesium toxicity, note the presence of a uterine contraction at the bottom of the tracing.
